palmidrol has been researched along with cannabidiol in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drmota, T; Elebring, T; Greasley, PJ; Hermansson, NO; Hjorth, S; Larsson, N; Leonova, J; Nilsson, K; Ryberg, E; Sjögren, S | 1 |
| Gerth, CW; Hellmich, M; Hoyer, C; Klosterkötter, J; Koethe, D; Leweke, FM; Muhl, D; Pahlisch, F; Piomelli, D | 1 |
| Faizi, M; Kahrizi, F; Naderi, N; Noorbakhsh, F; Rahimi, A; Talebi, F | 1 |
| Couch, DG; Lund, JN; O'Sullivan, SE; Tasker, C; Theophilidou, E | 1 |
| Babinska, Z; Bari, M; D'Addario, C; Di Bartolomeo, M; Di Marco, R; Di Marzo, V; Drago, F; Drazanova, E; Giurdanella, G; Iannotti, FA; Maccarrone, M; Mechoulam, R; Micale, V; Pekarik, V; Piscitelli, F; Ruda-Kucerova, J; Salomone, S; Starcuk, Z; Stark, T; Sulcova, A; Wotjak, CT | 1 |
| Barrett, D; Cook, H; Couch, DG; Lund, JN; O'Sullivan, SE; Ortori, C | 1 |
| Dellavalle, RP; Dunnick, CA; Fernandez, J; Lio, P; Maghfour, J; Rietcheck, H; Rundle, CW; Sivesind, TE; Szeto, MD; Yardley, H | 1 |
| Bogoda, N; Clayton, P; Hill, M; Subah, S; Venkatesh, R | 1 |
3 trial(s) available for palmidrol and cannabidiol
| Article | Year |
|---|---|
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia.
Topics: Acute Disease; Adult; Amides; Amisulpride; Antipsychotic Agents; Arachidonic Acids; Cannabidiol; Double-Blind Method; Drug Therapy, Combination; Endocannabinoids; Ethanolamines; Female; Humans; Male; Oleic Acids; Palmitic Acids; Polyunsaturated Alkamides; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Signal Transduction; Sulpiride; Young Adult | 2012 |
Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo-A Randomized, Placebo-controlled, Double-blind Controlled Trial.
Topics: Adolescent; Adult; Amides; Anti-Inflammatory Agents, Non-Steroidal; Caco-2 Cells; Cannabidiol; Cell Membrane Permeability; Double-Blind Method; Ethanolamines; Follow-Up Studies; Gastrointestinal Tract; Humans; Inflammation; Inflammatory Bowel Diseases; Male; Middle Aged; Palmitic Acids; Young Adult | 2019 |
Tolerability profile of topical cannabidiol and palmitoylethanolamide: a compilation of single-centre randomized evaluator-blinded clinical and in vitro studies in normal skin.
Topics: Administration, Topical; Amides; Cannabidiol; Cannabis; Chorioallantoic Membrane; Dermatitis, Irritant; Dermatitis, Phototoxic; Ethanolamines; Humans; In Vitro Techniques; Palmitic Acids; Plant Extracts; Single-Blind Method | 2021 |
5 other study(ies) available for palmidrol and cannabidiol
| Article | Year |
|---|---|
The orphan receptor GPR55 is a novel cannabinoid receptor.
Topics: Amino Acid Sequence; Animals; Arachidonic Acids; Binding Sites; Binding, Competitive; Cannabidiol; Cannabinoids; Cell Line; Cloning, Molecular; Cyclohexanols; Down-Regulation; Endocannabinoids; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Ligands; Mice; Molecular Sequence Data; Organ Specificity; Polymerase Chain Reaction; Polyunsaturated Alkamides; Rats; Receptors, Cannabinoid; Receptors, G-Protein-Coupled; RNA, Messenger; Signal Transduction; Structure-Activity Relationship | 2007 |
Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice.
Topics: Amides; Animals; Anti-Inflammatory Agents; Axons; Cannabidiol; Drug Therapy, Combination; Encephalomyelitis, Autoimmune, Experimental; Ethanolamines; Female; Interferon-gamma; Interleukin-17; Macrophages; Mice, Inbred C57BL; Microglia; Myelin Sheath; Neuroimmunomodulation; Palmitic Acids; Severity of Illness Index; Spinal Cord; Treatment Outcome; Tumor Necrosis Factor-alpha | 2015 |
Cannabidiol and palmitoylethanolamide are anti-inflammatory in the acutely inflamed human colon.
Topics: Acute Disease; Amides; Anti-Inflammatory Agents; Caco-2 Cells; Cannabidiol; Colon; Cytokines; Ethanolamines; Humans; Inflammatory Bowel Diseases; Palmitic Acids; Tumor Necrosis Factor-alpha | 2017 |
Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia.
Topics: Amides; Animals; Arachidonic Acids; Cannabidiol; Disease Models, Animal; Endocannabinoids; Ethanolamines; Female; Glycerides; Hippocampus; Interpersonal Relations; Male; Methylazoxymethanol Acetate; Motor Activity; Oleic Acids; Palmitic Acids; Piperidines; Polyunsaturated Alkamides; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Puberty; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Recognition, Psychology; RNA, Messenger; Schizophrenia | 2019 |
Palmitoylethanolamide: A Potential Alternative to Cannabidiol.
Topics: Amides; Cannabidiol; Cannabis; Endocannabinoids; Ethanolamines; Humans | 2023 |